All News

Secretary of US Health and Human Services Robert F. Kennedy Jr also approved all recommendations issued from the April ACIP meeting.

With the company’s dedication to providing crucial data for pharmacy stakeholders, IQVIA’s Lead Research Director Michael Kleinrock discussed the current trends in patients’ medication use.

LEO Pharma’s topical medication was shown to be safe and effective in adult patients with moderate-to-severe hand eczema.

The risk of untreated depression for pregnant women can cause adverse outcomes, which can include relapse in mood symptoms, suicide, and overdose death.

Women with premature ovarian insufficiency experience a high prevalence of depressive symptoms, highlighting the need for comprehensive, multidisciplinary care.

This episode introduces the hosts and explores key legal issues facing independent pharmacies, including PBM terminations and state board compliance.

Amid uncertainty about the best factors for measuring and defining pharmacy deserts, researchers explored the impacts of drive time and inequities in pharmacy access.

Pharmacists can improve insulin safety and adherence by combining in-person counseling with practical tools, regular check-ins, and proactive education.

Michael Murphy, PharmD, MBA, provided insights on his research regarding pharmacy deserts, who they impact the most, and the methods needed to improve them in the US.

Flu vaccination significantly reduces illness in vaccinated and unvaccinated individuals, highlighting its importance in public health strategies.

From 2008 to 2023, the relative increase of pediatric patients with obesity classes 4 to 5 was 253.1%.

With an emphasis on the factors that differentiate the future roles of pharmacists, researchers sought to better understand the career intentions of pharmacy students.

Pharmacists are now seeking roles that offer better well-being, flexibility, and long-term satisfaction beyond traditional practice settings.

Pharmacists play a key role in monitoring insulin use by addressing dosing, storage, and symptom management through regular, supportive patient check-ins.

In part 4 of our interview with Michael Kleinrock, lead director of research at IQVIA, he discussed how trends in medication use are currently impacting pharmacy businesses.

The FDA approves Kirsty, an interchangeable biosimilar insulin, enhancing diabetes treatment options and accessibility for patients.

More pharmacists are moving into nontraditional roles within health care, driven by limited advancement opportunities, stagnant wages, and a growing desire for flexibility

Michael Murphy, PharmD, MBA, discusses how the lack of a universal definition for pharmacy deserts is leading to a significant impact on patients’ access and outcomes.

Community pharmacists play a crucial role in helping patients start insulin with confidence through education, emotional support, and hands-on guidance.

Using the Q Methodology to account for subjectivity in responses, pharmacists self-identified their professional identities.

New study data reveal the waning effectiveness of 2023-2024 COVID-19 vaccines, highlighting the need for ongoing vaccinations and pharmacist involvement.

Older adults with insomnia face heightened depression risks during inflammation, highlighting the need for targeted monitoring and treatment strategies.

In the researchers’ exploration of post-ICU nutritional care, they detailed the clinical pharmacist’s role and provided insights into how this role may evolve in the future.

Perceptions of pharmacy as a long-term career have evolved significantly in recent years due to shifts in education, work roles, and workplace challenges.

Susan Cornell, PharmD, CDCES, FAPhA, FADCES, discusses how pharmacists can explain insulin timing and mealtime coordination effectively to patients.

Emphasizing the pharmacist’s essential role, researchers explored the causes, consequences, and clinical implications of polypharmacy.

This year’s conference is taking place from August 1 to 4 in Cincinnati, Ohio.

IQVIA’s Lead Director of Research Michael Kleinrock discusses how federal policy has been impacting prescription drug costs in the US and where those trends are expected to go.